American Academy of Sleep Medicine   Report issue

Foundation Phase 2 Phase 4
Founded: Darien IL United States (1975)

Organization Overview

First Clinical Trial
2009
NCT00869869
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

American Academy of Sleep Medicine

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cataplexy (Phase 2)

Disorders of Excessive Somnolence (Phase 2)

Heart Failure (Phase 2)

Idiopathic Hypersomnia (Phase 2)

Narcolepsy (Phase 2)

Parasomnias (Phase 2)

Sleep Wake Disorders (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 8